<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05610436</url>
  </required_header>
  <id_info>
    <org_study_id>2022PI148</org_study_id>
    <nct_id>NCT05610436</nct_id>
  </id_info>
  <brief_title>Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors</brief_title>
  <acronym>SYNPOCov</acronym>
  <official_title>Post-Covid Condition Monitoring Cohort: Evaluation of the Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our cohort is to collect prospectively, in a standardized and exhaustive manner,&#xD;
      the health data of patients referred to the CAPCoV, our holistic referal post covid clinics&#xD;
      for post-covid condition in order to be able to identify typical profiles of patients&#xD;
      suffering from post covid syndrome and to follow the evolution of their disease over time.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 7, 2022</start_date>
  <completion_date type="Anticipated">June 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Symptoms</measure>
    <time_frame>every 6 months up to 3 years</time_frame>
    <description>Symptoms collected in a standardized manner during consultations, their persistence over time, their evolution (improvement, stagnation, worsening) and their severity (mild, moderate, severe)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medical history</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fatigue</measure>
    <time_frame>every 6 months up to 3 years</time_frame>
    <description>Chalder scale: range 0 to 33, &gt;22/33 classified severe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>every 6 months up to 3 years</time_frame>
    <description>mMRC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive impairement</measure>
    <time_frame>every 6 months up to 3 years</time_frame>
    <description>Montréal Cognitive Assessment : range 0 to 30, &lt;26/30 classified pathologic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inappropriate hyperventilation syndrome</measure>
    <time_frame>every 6 months up to 3 years</time_frame>
    <description>Nijmegen score: range 0 to 64, &gt;23/34 classified &quot;possible inapropriate hyperventilation&quot; syndrome&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>additional examinations</measure>
    <time_frame>every 6 months up to 3 years</time_frame>
    <description>Biology, imaging</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Long COVID</condition>
  <condition>Post-Acute COVID-19</condition>
  <condition>Post-Acute COVID19 Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        outpatients treated in the Nancy University Hospital Long Covid Support and Care Center for&#xD;
        post-Covid condition according to WHO definition&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  outpatients treated in the Nancy University Hospital Long Covid Support and Care&#xD;
             Center for post-Covid condition according to WHO definition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient opposing the processing for research purposes of their data collected in&#xD;
             routine care for their care&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francois GOEHRINGER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Infectious Diseases Department, Nancy University Hospital,F-54000 Nancy, France.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francois GOEHRINGER, MD</last_name>
    <phone>+33383154097</phone>
    <email>francois.goehringer@chru-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nancy University Hospital</name>
      <address>
        <city>Vandoeuvre les nancy</city>
        <state>Grand Est</state>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francois GOEHRINGER, MD</last_name>
      <phone>+33383154097</phone>
      <email>francois.goehringer@chru-nancy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2022</verification_date>
  <study_first_submitted>October 20, 2022</study_first_submitted>
  <study_first_submitted_qc>November 8, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2022</study_first_posted>
  <last_update_submitted>November 8, 2022</last_update_submitted>
  <last_update_submitted_qc>November 8, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>GOEHRINGER François</investigator_full_name>
    <investigator_title>Principal Investigator, clinical physician, Infectious Diseases department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

